We are thrilled to announce that we will collaborate with the American Diabetes Association® (ADA) to host the 25th Annual Diabetes Technology Meeting (DTM) in October.
The DTM offers an exceptional opportunity to engage with leading scientists and clinicians in diabetes research and explore cutting-edge technological advancements in diabetes care. Building on the success of last year's event, which attracted over 400 clinicians and scientists internationally, we anticipate an even more diverse and dynamic gathering in 2025.
Registration will open in April, but in the meantime please save the date for the 25th DTM, which is scheduled for Oct. 28-30 in Burlingame, California. Through our newly established collaboration with the ADA, DTM 2025 promises a scientific conference of unprecedented value and insight for the diabetes community.
Our primary objective remains to foster connections between technology developers and users, thus facilitating the creation of innovative and cost-effective management tools for individuals living with diabetes. Key programming for this year’s DTM includes:
- Thought provoking scientific sessions
- Comprehensive updates on current U.S. regulatory policies, presented by FDA officials
- A new exhibit hall this year featuring technology products
- State-of-the-art lectures, engaging panel discussions, and a dynamic poster session over two evenings
As a token of our appreciation, every attendee will receive a complimentary one-year subscription to the Journal of Diabetes Science and Technology (JDST). This peer-reviewed bimonthly scientific journal, indexed by the National Library of Medicine for MEDLINE/PubMed, stands as the world's first purely electronic diabetes journal, offering cutting-edge research at your fingertips. JDST publishes the most articles about diabetes technology of any journal in the world.
We look forward to seeing you at DTM 2025, where we can connect in person, share insights on projects of mutual interest, and be part of shaping the future of diabetes technology and care.